Response Biomedical Corp. (Response), a global provider of acute care diagnostic testing solutions, is announcing today that Health Canada has granted the RAMP® COVID-19 Antigen Test authorization to commercialize under the… Read More
Phase III GRADUATE studies did not meet their primary endpoints of slowing clinical decline in people with early Alzheimer’s The level of beta-amyloid removal by gantenerumab was lower than expected Topline data… Read More
OTTAWA, ON – Innovative Medicines Canada (IMC) is calling on Health Canada to direct the Patented Medicine Prices Review Board (PMPRB) to suspend its current Guidelines consultation process. If the PMPRB’s… Read More
Expanded characterization of CD3-binding antibodies includes identification of antibodies that bind regions of CD3 that are distinct from commonly used molecules Robust proof-of-concept study demonstrates T-cell engagers that potently eliminate… Read More
CPHI Award recognizes cross-industry innovators Collaboration with Stanford University Maximizing potential of mRNA therapeutics ESSEN, DE — Evonik Health Care has won the prestigious CPHI Excellence in Pharma Award in… Read More
